Pricing Log in Create free account

MapLight Therapeutics, Inc. (MPLT) vs Rezolute, Inc. (RZLT)

MapLight Therapeutics, Inc. and Rezolute, Inc. are both Biotechnology companies. MapLight Therapeutics, Inc. and Rezolute, Inc. are of similar size ($352.1M and $345.7M). Across the 9 metrics below, Rezolute, Inc. leads on 6 and MapLight Therapeutics, Inc. on 3.

Valuation

Metric MPLT RZLT Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 0.89 3.97 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (616.76%) (19.74%) (32.88%)
Free cash flow yield (56.19%) (16.35%) (23.13%)

Profitability

Metric MPLT RZLT Biotechnology median
Gross margin — 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (297.18%) (59.04%) (51.96%)
Return on assets (124.79%) (53.82%) (46.06%)
Return on invested capital (348.44%) 0.00% 0.00%

Growth

Metric MPLT RZLT Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 82.39% 23.47% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric MPLT RZLT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 16.52 9.68 4.97
Net debt to EBITDA 1.79 1.26 1.01

Dividend

Metric MPLT RZLT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric MPLT RZLT Biotechnology median
Market cap 345.68m 352.10m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack